摘要
目的探讨急性脑梗死患者治疗前后血浆Lp A、D二聚体及hsCRP水平的变化及意义。方法选取2014年12月—2016年12月来我院收治的50例急性脑梗死患者作为观察组,另选取此阶段来院体检的健康者50例作为对照组。对比两组患者的血浆Lp A、D二聚体及hsCRP水平以及观察组患者治疗前后血浆Lp A、D二聚体及hs-CRP水平的变化。结果观察组患者的血浆Lp A、D二聚体及hs-CRP水平均高于对照组,差异具有统计学意义(P<0.05)。观察组患者治疗后,血浆Lp A、D二聚体及hs-CRP水平较治疗前低,差异具有统计学意义(P<0.05)。结论急性脑梗死患者血浆Lp A、D二聚体及hs-CRP水平,具有可靠的临床意义,可以作为临床指标反映患者的病情,是临床用于急性脑梗死诊治的重要选择。
Objective To investigate the changes and significance of plasma LpA, D dimer and hs-CRP levels in patients with acute cerebral infarction before and after treatment. Methods 50 cases of patients with acute cerebral infarction admitted to our hospital from December 2014 to December 2016 were selected as the observation group. 50 cases of patients who were admitted to this hospital were selected as the control group. The levels of plasma LpA, D dimer and hs-CRP in plasma and the changes of plasma LpA, D dimer and hs-CRP levels were observed before and after treatment. Results The levels of plasma LpA, D dimer and hs-CRP in the observation group were significantly higher than those in the control group （P〈0.05）. Plasma LpA, D dimer and hs-CRP levels were significantly lower in patients with acute cerebral infarction than betbre treatment （P〈0.05）. Conclusion The levels of plasma LpA, D dimer and hs-CRP in patients with acute cerebral infarction are reliable and can be used as clinical indicators to reflect the condition of patients. It is an important choice for the diagnosis and treatment of acute cerebral infarction. It is worthy of clinical application.
出处
《中国继续医学教育》
2017年第15期95-97,共3页
China Continuing Medical Education
